The Argus II Retinal Prosthesis System, called a "bionic eye" by some, has become the first FDA-approved implanted device to improve vision loss due to advanced retinitis pigmentosa.
Ophthalmology
Geisinger-Shamokin (Pa.) Area Community Hospital has begun construction on a new 4,000-foot, $1.2 million ophthalmology clinic at the Geisinger Specialty Care–Shamokin facility on the hospital's grounds.
Global eye drug and device company Bausch + Lomb announced its Victus femtosecond laser has received 510(k) clearance from the FDA to create arcuate incisions in the cornea.
The Gavin Herbert Eye Institute at the UC Irvine Health system has received a $3 million research grant for age-related macular degeneration and retinitis pigmentosa, according to a news release.
The National Eye Institute recognized 10 ophthalmologists and eye specialists in its Audacious Goals Challenge, awarding winning one-page proposals to advance eye research and medicine with $3,000 and an opportunity to present their ideas at a conference hosted in Washington,…
A study published in JAMA Ophthalmology showed further evidence linking the predictive nature of high-sensitivity C-reactive protein in risk of age-related macular degeneration.
Post-operative cataract patients treated with Loteprednol etabonate as a gel or vehicle four times a day for two weeks saw significant reduction in pain and inflammation, according to a study published in the Journal of Cataract & Refractive Surgery.
San Antonio Eye Center in Texas opened a new 6,000-square-foot location in the city, culminating a two year renovation project to convert the facility from a historical home, according to a news release.
Elmhurst (Ill.) Outpatient Surgery Center announced in a news release they are the state's first outpatient surgery facility to offer Catalys Precision Laser System treatments for cataract and astigmatic procedures.
Three ophthalmologists of the Eye Clinic of Texas have been named "Best Doctors" in a peer survey that rates them in the top 5 percent of U.S. physicians, according to a news release.
